Rituximab in refractory ophthalmic Wegener's granulomatosis: PR3 titers may predict relapse, but repeat treatment can be effective

Ophthalmology

Volumn 118, Issue 12, 2011, Pages 2498-2503

  Joshi, Lavnish ^a,b   Lightman, Sue L ^a,b   Salama, Alan D ^b,c   Shirodkar, Amy Lee ^a,b   Pusey, Charles D ^b,d   Taylor, Simon R J ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PREDNISOLONE; RITUXIMAB;

ACUTE CORONARY SYNDROME; ARTICLE; B LYMPHOCYTE; BLADDER CANCER; BLADDER CARCINOMA; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG SAFETY; EYE DISEASE; FOLLOW UP; HUMAN; LYMPHOCYTE SUBPOPULATION; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS PNEUMONIA; RECURRENT DISEASE; REFRACTORY OPHTHALMIC WEGENER GRANULOMATOSIS; REFRACTORY OPTHALMIC WEGENER GRANULOMATOSIS; RELAPSE; REMISSION; RETREATMENT; RETROSPECTIVE STUDY; RISK FACTOR; SCLERITIS; TIME; TREATMENT DURATION; TREATMENT RESPONSE; UPPER RESPIRATORY TRACT INFECTION; VISUAL ACUITY; WEGENER GRANULOMATOSIS;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; AUTOANTIBODIES; B-LYMPHOCYTES; EYE DISEASES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MYELOBLASTIN; RECURRENCE; RETREATMENT; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME; WEGENER GRANULOMATOSIS; YOUNG ADULT;

EID: 80053946823     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2011.06.009     Document Type: Article

References (33)

1. D. Jayne, N. Rasmussen, K. Andrassy European Vasculitis Study Group A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies N Engl J Med 349 2003 36 44 (Pubitemid 36765101)
2. K.W. Westman, P.G. Bygren, and H. Olsson Relapse rate, renal survival, and cancer morbidity in patients with Wegener's granulomatosis or microscopic polyangiitis with renal involvement J Am Soc Nephrol 9 1998 842 852 (Pubitemid 28209094)
3. P. Stashenko, L.M. Nadler, R. Hardy, and S.F. Schlossman Characterization of a human B lymphocyte-specific antigen J Immunol 125 1980 1678 1685 (Pubitemid 10018582)
4. A. Bar-Or, P.A. Calabresi, and D. Arnold Rituximab in relapsing-remitting multiple sclerosis: a 72-week, open-label, phase I trial Ann Neurol 63 2008 395 400 (Pubitemid 351499869)
5. M.J. Leandro, G. Cambridge, and J.C. Edwards B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients Rheumatology (Oxford) 44 2005 1542 1545 (Pubitemid 41742472)
6. P.J. Mease, D.A. Revicki, and J. Szechinski Improved health-related quality of life for patients with active rheumatoid arthritis receiving rituximab: results of the dose-ranging assessment: International Clinical Evaluation of Rituximab in Rheumatoid Arthritis (DANCER) Trial J Rheumatol 35 2008 20 30
7. R.B. Jones, J.W. Tervaert, T. Hauser European Vasculitis Study Group Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis N Engl J Med 363 2010 211 220
8. J.H. Stone, P.A. Merkel, R. Spiera RAVE-ITN Research Group Rituximab versus cyclophosphamide for ANCA-associated vasculitis N Engl J Med 363 2010 221 232
9. K.A. Keogh, M.E. Wylam, J.H. Stone, and U. Specks Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 52 2005 262 268 (Pubitemid 40129256)
10. K.A. Keogh, S.R. Ytterberg, and F.C. Fervenza Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial Am J Respir Crit Care Med 173 2006 180 187 (Pubitemid 43187890)
11. U. Specks, F.C. Fervenza, T.J. McDonald, and M.C. Hogan Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy Arthritis Rheum 44 2001 2836 2840 (Pubitemid 34016203)
12. S.R. Taylor, A.D. Salama, and L. Joshi Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis Arthritis Rheum 60 2009 1540 1547
13. C.M. Cheung, P.I. Murray, and C.O. Savage Successful treatment of Wegener's granulomatosis associated scleritis with rituximab [letter] Br J Ophthalmol 89 2005 1542 (Pubitemid 41527407)
14. J. Freidlin, I.G. Wong, and N. Acharya Rituximab treatment for peripheral ulcerative keratitis associated with Wegener's granulomatosis [letter] Br J Ophthalmol 91 2007 1414 (Pubitemid 47492887)
15. P.M. Aries, B. Hellmich, and J. Voswinkel Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations Ann Rheum Dis 65 2006 853 858
16. B. Brihaye, A. Aouba, and C. Pagnoux Adjunction of rituximab to steroids and immunosuppressants for refractory/relapsing Wegener's granulomatosis: a study on 8 patients Clin Exp Rheumatol 25 suppl 2007 S23 S27 (Pubitemid 46656590)
17. R. Omdal, K. Wildhagen, and T. Hansen Anti-CD20 therapy of treatment-resistant Wegener's granulomatosis: favourable but temporary response Scand J Rheumatol 34 2005 229 232 (Pubitemid 40978644)
18. N. Tamura, R. Matsudaira, and M. Hirashima Two cases of refractory Wegener's granulomatosis successfully treated with rituximab Intern Med 46 2007 409 414 (Pubitemid 46585484)
19. R. Stasi, E. Stipa, and G. Del Poeta Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab Rheumatology (Oxford) 45 2006 1432 1436 (Pubitemid 44605482)
20. J.C. Jennette, R.J. Falk, and K. Andrassy Nomenclature of systemic vasculitides: proposal of an international consensus conference Arthritis Rheum 37 1994 187 192 (Pubitemid 24065492)
21. R.Y. Leavitt, A.S. Fauci, and D.A. Bloch The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis Arthritis Rheum 33 1990 1101 1107 (Pubitemid 20273294)
22. B. Hellmich, O. Flossmann, and W.L. Gross EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis Ann Rheum Dis 66 2007 605 617 (Pubitemid 46707128)
23. R.B. Jones, A.J. Ferraro, and A.N. Chaudhry A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis Arthritis Rheum 60 2009 2156 2168
24. K. de Groot, W.L. Gross, K. Herlyn, and E. Reinhold-Keller Development and validation of a Disease Extent Index for Wegener's granulomatosis Clin Nephrol 55 2001 31 38 (Pubitemid 32041780)
25. M. Shenin, M. Naik, and C.T. Derk The use of mycophenolate mofetil for the treatment of systemic sclerosis Endocr Metab Immune Disord Drug Targets 8 2008 11 14
26. R.D. Swartz, A.M. Lake, and W.W. Roberts Idiopathic retroperitoneal fibrosis: a role for mycophenolate mofetil Clin Nephrol 69 2008 260 268 (Pubitemid 351516269)
27. A.D. Dick, P. Meyer, and T. James Campath-1H therapy in refractory ocular inflammatory disease Br J Ophthalmol 84 2000 107 109 (Pubitemid 30251643)
28. A.J. Ferraro, S.W. Smith, D. Neil, and C.O. Savage Relapsed Wegener's granulomatosis after rituximab therapy-B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood Nephrol Dial Transplant 23 2008 3030 3032
29. H. Genberg, A. Hansson, and A. Wernerson Pharmacodynamics of rituximab in kidney allotransplantation Am J Transplant 6 2006 2418 2428 (Pubitemid 44359429)
30. K. Vos, R.M. Thurlings, and C.A. Wijbrandts Early effects of rituximab on the synovial cell infiltrate in patients with rheumatoid arthritis Arthritis Rheum 56 2007 772 778 (Pubitemid 46399424)
31. P.I. Rafailidis, O.K. Kakisi, K. Vardakas, and M.E. Falagas Infectious complications of monoclonal antibodies used in cancer therapy: a systematic review of the evidence from randomized controlled trials Cancer 109 2007 2182 2189 (Pubitemid 46805005)
32. G. Cambridge, M.J. Leandro, and J.C. Edwards Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis Arthritis Rheum 48 2003 2146 2154 (Pubitemid 36959194)
33. N. Cooper, E.G. Davies, and A.J. Thrasher Repeated courses of rituximab for autoimmune cytopenias may precipitate profound hypogammaglobulinaemia requiring replacement intravenous immunoglobulin [letter] Br J Haematol 146 2009 120 122